secwatch.observer — SEC 8-K summary
======================================

Issuer:     Apyx Medical Corp (APYX)
CIK:        0000719135
Form:       8-K
Filed at:   2026-07-24T21:18:18+00:00
Accession:  0001493152-26-034619
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Apyx Medical reconstitutes board committees; Executive Chairman Vizirgianakis steps off all committees
--------------------------------------------------------------------------------

- Audit Committee: Lawrence J. Waldman (Chair), Minnie Baylor-Henry, Wendy Levine.
- Governance & Nominating: Baylor-Henry (Chair), Waldman, Levine; Regulatory Compliance: Baylor-Henry (Chair), Waldman, Levine; Compensation: Levine (Chair), Waldman, Baylor-Henry.
- Stavros Vizirgianakis, appointed Executive Chairman June 11, 2026, will not serve on any committee.
- Board determined all three members independent; Waldman qualifies as audit committee financial expert.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/719135/000149315226034619/0001493152-26-034619-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/719135/000149315226034619/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-034619

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer